Instytut Pomnik Centrum Zdrowia Dziecka

Warsaw, Masovian Voivodeship 04730

3 studies enrolling now · 6 studies all time

What they study most

Autosomal Recessive Polycystic Kidney (ARPKD), Colitis, Ulcerative, Crohn's Disease, Crohn's Disease (CD), Primary Immunodeficiency Diseases (PID), Ulcerative Colitis

Studies at this site

• A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) — Recruiting now
• A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease — Recruiting now
• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) — Recruiting now
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) — Recruiting now
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) — Completed
• A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases — Completed